References
- URL: http://www.alsuntangled.com/open.php. Accessed: February 3, 2017. (Archived by WebCite® at http://www.webcitation.org/6o0TmDPqn)
- Frecksa E, Bokor P, Winkelman M. The therapeutic potential of ayahuasca: possible effects against various diseases of civilization. Front Pharmacol. 2016;7:1–17.
- Dominguez-Clave E, Soler J, Elices M, Pascual JC, Alvarez E, de la Fuente Revenga M, et al. Ayahuasca: Pharmacology, neuroscience and therapeutic potential. Brain Res Bull. 2016;126(Pt 1):89–101.
- McKenna DJ, Towers GH, Abbott F. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca. J Ethnopharmacol. 1984;10:195–223.
- Gonzalez-Maeso J, Sealfon SC. Agonist-trafficking and hallucinogens. Curr Med Chem. 2009;16:1017–27.
- Fontanilla D, Johannessen M, Hajipour AR, Cozzi NV, Jackson MB, Ruoho AE. The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science. 2009;323:934–7.
- Li Y, Sattler R, Yang EJ, Nunes A, Ayukawa Y, Akhtar S, et al. Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression. Neuropharmacology. 2011;60:1168–75.
- Heise CW, Brooks DE. Ayahuasca exposure: descriptive analysis of calls to US Poison Control Centers from 2005 to 2015. J Med Toxicol. 2016. [Epub ahead of print].
- Ono Y, Tanaka H, Takata M, Nagahara Y, Noda Y, Tsuruma K, et al. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models. Neurosci Lett. 2014;559:174–8.
- Callaway JC, Brito GS, Neves ES. Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis. J Psychoactive Drugs. 2005;37:145–50.
- Cudkowicz ME, Titus S, Kearney M, Yu H, Sherman A, Schoenfeld D, et al. Safety and efficacy of ceftriaxone for amyotrophic lateral sclerosis: a multi-stage, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2014;13:1083–91.
- Naoi M, Riederer P, Maruyama W. Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression. J Neural Transm (Vienna). 2016;123:91–106.
- Gaujac A, Aquino A, Navickiene S, de Andrade JB. Determination of N,N-dimethyltryptamine in Mimosa tenuiflora inner barks by matrix solid-phase dispersion procedure and GC-MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2012;881-882:107–10.
- Koschnitzky JE, Quinlan KA, Lukas TJ, Kajtaz E, Kocevar EJ, Mayers WF, et al. Effect of fluoxetine on disease progression in a mouse model of ALS. J Neurophysiol. 2014;111:2164–76.
- Sandyk R. Serotonergic mechanisms in amyotrophic lateral sclerosis. Int J Neurosci. 2006;116:775–826.
- Mavlyutov TA, Guo LW, Epstein ML, Ruoho AE. Role of the Sigma-1 receptor in Amyotrophic Lateral Sclerosis (ALS). J Pharmacol Sci. 2015;127:10–16.
- URL:http://www.ayahuascatreatment.wordpress.com. Accessed: February 3, 2017. (Archived by WebCite® at http://www.webcitation.org/6o0Tuxo4J)
- Emails between ALSUntangled and Daniel Gustafsson, Jan. 2017.
- URL:https://www.patientslikeme.com/forum/als/topics/130226?page=2&prompt=condition_infos_any. Accessed: February 3, 2017. (Archived by WebCite® at http://www.webcitation.org/6o0TNOgsm)
- URL:http://www.als.net/forum/yaf_postsm404045_ayahuasca–potential-treatment-.aspx. Accessed: February 3, 2017. (Archived by WebCite® at http://www.webcitation.org/6o0U3gava)
- Sanches RF, de Lima Osorio F, Dos Santos RG, Macedo LR, Maia-de-Oliveira JP, Wichert-Ana L, et al. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a SPECT study. J Clin Psychopharmacol. 2016;36:77–81.
- Dos Santos RG, Valle M, Bouso JC, Nomdedeu JF, Rodriguez-Espinosa J, McIlhenny EH, et al. Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine. J Clin Psychopharmacol. 2011;31:717–26.
- Riba J, Valle M, Urbano G, Yritia M, Morte A, Barbanoj MJ. Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics. J Pharmacol Exp Ther. 2003;306:73–83.
- Dos Santos RG, Grasa E, Valle M, Ballester MR, Bouso JC, Nomdedeu JF, et al. Pharmacology of ayahuasca administered in two repeated doses. Psychopharmacology (Berl). 2012;219:1039–53.
- Riba J, Rodriguez-Fornells A, Urbano G, Morte A, Antonijoan R, Montero M, et al. Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers. Psychopharmacology (Berl). 2001;154:85–95.
- Osorio Fde L, Sanches RF, Macedo LR, Santos RG, Maia-de-Oliveira JP, Wichert-Ana L, et al. Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Rev Bras Psiquiatr. 2015;37:13–20.
- Flockhart DA. Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatry. 2012;73(Suppl 1):17–24.
- Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352:1112–20.
- Dantas AF, Riet-Correa F, Medeiros RM, Lopes JR, Gardner DR, Panter K, et al. Embryonic death in goats caused by the ingestion of Mimosa tenuiflora. Toxicon. 2012;59:555–7.
- Pimentel LA, Correa FR, Gardner D, Panter KE, Dantas AF, Medeiros RM, et al. Mimosa tenuiflora as a cause of malformations in ruminants in the northeastern Brazilian semiarid rangelands. Vet Pathol. 2007;44:928–31.
- Medeiros RM, de Figueiredo AP, Benicio TM, Dantas FP, Riet-Correa F. Teratogenicity of Mimosa tenuiflora seeds to pregnant rats. Toxicon. 2008;51:316–19.
- Gardner D, Riet-Correa F, Lemos D, Welch K, Pfister J, Panter K. Teratogenic effects of Mimosa tenuiflora in a rat model and possible role of N-methyl- and N,N-dimethyltryptamine. J Agric Food Chem. 2014;62:7398–401.
- Du W, Aloyo VJ, Harvey JA. Harmaline competitively inhibits [3H]MK-801 binding to the NMDA receptor in rabbit brain. Brain Res. 1997;770:26–9.
- URL:https://twitter.com/hellspawn_dg/status/790801600302477313. Accessed: February 3, 2017. (Archived by WebCite® at http://www.webcitation.org/6o0U67j9Q)
- URL:http://www.ebay.com/itm/100-ML-5-FLOZ-10X-VINEGAR-EXTRACT-Wild-Yellow-Banisteriopsis-Caapi-/271888608342. Accessed: February 3, 2017. (Archived by WebCite® at http://www.webcitation.org/6o0U82bO2)